WASHINGTON (Oct. 23, 2012)—According to the Centers for Disease Control and Prevention, more than 280 people now have meningitis caused by taking contaminated drugs sold by a compounding pharmacy that is under investigation. Federal authorities believe the company sold steroid drugs that were tainted with two different types of fungus, which then led to meningitis.
Experts from the George Washington University (GW) School of Medicine and Health Sciences are available to discuss fungal meningitis. They include:
• Gary Simon, MD, PhD, Director of the Division of Infectious Diseases and the Walter G. Ross Professor of Medicine and of Microbiology & Tropical Medicine
• David Parenti, MD, Director of the Traveler’s Clinic and Professor of Medicine
• Marc Siegel, MD, Assistant Professor of Medicine
To find out more about the regulatory environment that led to the current outbreak and potential policy solutions, read a GWToday interview with Ruth Lopert, Visiting Professor of Health Policy at the GW School of Public Health and Health Services. Lopert is also available for media inquiries.
To interview Professors Simon, Parenti or Siegel please contact Anne Banner at 202-994-2261 or email@example.com.